Breadcrumb

  1. Our vision
  2. EMEA News

EMEA News

Displaying 1 - 10 of 16
Thu 10 October, 2019
Geneva, Switzerland – Santen EMEA is proud to support World Sight Day (WSD) 2019, an annual initiative hosted by the International Association for the Prevention of Blindness (IAPB). WSD is an…
Mon 16 September, 2019
CE marked and approved as a monofocal hydrophobic intraocular lens (IOL), the xact™ Mono-EDoF™ is a hydrophobic diffractive IOL with 4 diffractive rings developed by Santen1 Provides excellent…
Fri 6 September, 2019
Geneva, Switzerland – Santen EMEA’s significant expansion into the surgical devices arena is underlined by the company’s activities at this year’s European Society of Cataract and Refractive Surgeons…
Wed 4 September, 2019
Santen is delighted to have the opportunity to make our first appearance and start discussions with customers at the XIV International Congress of the Middle East and Africa Council of Ophthalmology…
Wed 26 June, 2019
Oxford, UK and Osaka, Japan – Oxford Biomedica plc (LSE:OXB) a leading gene and cell therapy group, and Santen Pharmaceutical Co., Ltd., the market leader for prescription ophthalmic pharmaceuticals…
Thu 13 June, 2019
Geneva, Switzerland – Santen EMEA is delighted to share the preliminary results of its two real world evidence (RWE) studies, VISIONARY and PERSPECTIVE at this year’s European Society of…
Wed 13 March, 2019
Santen and the International Glaucoma Association (IGA) have joined forces to create a unique interactive 'eye test' to demonstrate what the world looks like to people living with glaucoma. The test…
Mon 25 February, 2019
Today Santen announces that the preservative-free, formulation Cosopt iMulti® (20mg/ml dorzolamide + 5mg/ml timolol eye drops, solution) and the preservative-free multi-dose formulation of Taflotan®/…
Thu 14 February, 2019
Santen EMEA is proud to have supported the 13th European Glaucoma Society’s two-day Residents’ Course held on 8-9 February 2019 in Mainz, Germany. Over 160 ophthalmology residents from across Europe…
Thu 15 November, 2018
OFF Italia S.r.l and Santen SA, the European subsidiary of Santen Pharmaceutical Co. Ltd., entered into a licence and supply agreement with the objective to extend the offering of OFF Italia’s…